At a Glance: Turning Discovery into Delivery
- People are the bridge: Building an integrated talent portfolio is your ultimate differentiator when moving from academic discovery to a viable market asset.
- The Founding Five framework: Early-stage organizations must secure five foundational, cross-functional roles to protect momentum and de-risk the pipeline for investors.
- High-stakes compliance pitfalls: Minor operational oversights can turn into devastatingly expensive lessons during due diligence.
- Character over credentials: Scaling with agility requires prioritizing resourcefulness over big-company resumes, defining clear decision trees early, and fiercely protecting organizational culture within your first ten hires.
Many life sciences organizations navigate a complex transition when moving an asset from academic discovery to a viable market product. While founders frequently approach this phase as a purely financial challenge, advanced lab space and equipment cannot substitute for the right team.
Capital provides the fuel, but people form the true bridge from discovery to delivery. Securing an integrated talent portfolio early is your ultimate differentiator – de-risking your pipeline for investors while protecting your capital runway.
Below, we outline the foundational cross-functional roles early-stage organizations need to secure to build a stable launchpad for growth.
The Founding Five: Building your talent launchpad
Life sciences companies often think about hiring as a series of isolated events.
Rather than hiring a scientist, then an advisor, then a consultant, and so on, building an integrated people portfolio that works together as one functioning body protects your runway and covers inevitable needs throughout the commercialization process.
Here are the most vital five roles that serve as the foundation:
The Architect – Head of R&D
Translates academic discovery into a repeatable, scalable platform. Hire someone who can manage a budget and a timeline, not just run an experiment.
The Operator – Head of Operations/Chief of Staff
Handles lab leases, HR, vendor management, and basic finance so scientists can focus on science. Important note: founders who skip this hire can quickly burn out on paperwork.
The Translator – Head of Clinical/Regulatory Strategy
Knows what FDA/EMA needs to see, while ensuring early R&D won't be rejected three years from now – a massive de-risking signal for investors.
The Swiss Army Knife – Senior Scientist/Lead Engineer
High-output and comfortable with ambiguity. Doesn't wait for a SOP – writes one. Important note: Avoid Big Pharma specialists; you need generalists who can troubleshoot and present.
The Storyteller – Head of Business Development
Distills complex data down to a compelling value proposition for VCs and Big Pharma partners.
By Hire 5, your organization will have a platform, a path, and early data – making it possible for you to focus on selling the vision.
“I realized that in the life sciences, there’s often a massive translation gap. Scientists speak the language of discovery, and investors speak the language of delivery. My job as a Search Practice Lead at Mix Talent is to lead a team of scientific and clinical recruiters – I’m essentially a 'talent architect' for companies that are currently in stealth or early phases, trying to figure out how to move from the bench to a clinical reality without running into all-too-common pitfalls.”
— Tori Schaefer, PhD, Senior Director, Client Solutions & Scientific Partnerships at Mix Talent
Common early-stage hiring pitfalls – and how to avoid them
Pitfall #1: Hiring for credentials, not character
Pitfall #2: Skipping the employment attorney
Pitfall #3: Misclassifying a contractor
Pitfall #4: Letting culture drift in the first 10 hires
Pitfall #5: Confusing speed with urgency
Pitfall #6: Underdirecting the first FTE
Assumed scientific autonomy can cause the assumption that no onboarding was needed. Unclear expectations kill retention far more quickly than low compensation.
The Founding Five structure can help insulate your organization from common missteps along the path to delivery, but perhaps even more important is getting it right the first time – because limited funding and runway can mean rehiring a vital role is not an option.
Now, let’s dive into some of the ways you can ensure the right people are in the right seats.
Best practices for early-stage life sciences hiring
BEST PRACTICE 1
Complement, don’t clone
The science alone is not enough. Seek partners with commercial instinct, regulatory fluency, and operational discipline – the gaps most life science founders leave unfilled.
BEST PRACTICE 2
Have the equity conversation early
Vague equity agreements become expensive disputes. Get specific before you start building – silence is not an agreement!
BEST PRACTICE 3
Define who has final decision
Who has final say on hiring, spending, or pivots? Misaligned authority structures are the number-one cause of co-founder breakdown – not disagreements on science.
BEST PRACTICE 4
Recognize patterns
Founding teams that survive are the ones where everyone builds. If someone is waiting for a playbook to appear, they’re not a startup founder.
Across each of these factors, perhaps the most important variable is your culture. In a 5-person company, everyone can see what they built. That’s genuinely rare and deeply motivating – to the right people. The ability to shape the company’s and its product’s future, not just execute someone else’s vision, is a powerful draw for PhD-level talent.
In short, your founding team should set the scientific and strategic vision from day one. Your core functional roles are your operational backbone – R&D, quality, regulatory, and data functions that drive execution. And infused in all of this should be brand, mission, and compensation strategies that attract and keep the best people.
When Talent is Everything – Get in the mix
Whether you’re planning your first commercial launch or rethinking your talent structure, Mix can help you design, build, and scale your organization – from full-scale field builds to flexible, contract-based models. We're here to help you find the right mix.
